ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.

For most of the past year or so, crypto evangelists had a powerful story on their side. Donald Trump’s return to power promised to be a breakthrough for the crypto space. In the three weeks after the ...